SBPH - スプリング・バンク・ファ―マシュ―ティカルズ (Spring Bank Pharmaceuticals Inc.)

SBPHのニュース

   ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm - SBPH, VAR, JCAP, GLIBA  2020/09/03 07:11:00 PR Newswire
NEW YORK, Sept. 3, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its…
   NASDAQ listing expected as F-star Therapeutics announces merger with Spring Bank Pharmaceuticals  2020/08/03 20:29:00 Cambridge Independent
The combined company will be headquartered at Babraham Research Campus and in Cambridge, Massachusetts.
   Spring Bank in clinical collaboration with Roche for SB 11285 in tumors  2020/02/25 13:41:06 Seeking Alpha
Spring Bank Pharmaceuticals (NASDAQ:SBPH) jumps 20% in premarket trading after announcing a clinical collaboration with Roche (OTCQX:RHHBY) (OTCQX:RHHBF) t
   Spring Bank (SBPH) Stops Dosing in HBV Studies, Stock Down  2019/12/27 08:04:00 Zacks Investment Research
Spring Bank (SBPH) declines as it stops dosing and enrolling patients in phase IIb studies on inarigivir.
   The Daily Biotech Pulse: Intuitive Surgical Earnings, Paratek Pulls Out European Application For Antibiotic, Amgen's Evenity In Europe  2019/10/18 11:07:56 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 17) Applied Therapeutics Inc (NASDAQ: APLT ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Celgene Corporation (NASDAQ: CELG ) Kodiak Sciences Inc (NASDAQ: KOD ) The Medicines Company (NASDAQ: MDCO ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 17) Aileron Therapeutics Inc (NASDAQ: ALRN ) Alpine Immune Sciences Inc (NASDAQ: ALPN ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Homology Medicines Inc (NASDAQ: FIXX ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM ) Neurometrix Inc (NASDAQ: NURO ) (reacted to its third-quarter results) Puma Biotechnology Inc (NASDAQ: PBYI ) Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) Theratechnologies Inc (NASDAQ: THTX ) Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) Stocks In Focus Intuitive Surgical Q3 Tops Expectations Intuitive Surgical, Inc. (NASDAQ: ISRG ) reported third-quarter earnings per share of $3.43 on revenues of $1.13 billion.
   Spring Bank in clinical collaboration with Roche for SB 11285 in tumors  2020/02/25 13:41:06 Seeking Alpha
Spring Bank Pharmaceuticals (NASDAQ:SBPH) jumps 20% in premarket trading after announcing a clinical collaboration with Roche (OTCQX:RHHBY) (OTCQX:RHHBF) t
   Spring Bank (SBPH) Stops Dosing in HBV Studies, Stock Down  2019/12/27 08:04:00 Zacks Investment Research
Spring Bank (SBPH) declines as it stops dosing and enrolling patients in phase IIb studies on inarigivir.
   The Daily Biotech Pulse: Intuitive Surgical Earnings, Paratek Pulls Out European Application For Antibiotic, Amgen's Evenity In Europe  2019/10/18 11:07:56 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 17) Applied Therapeutics Inc (NASDAQ: APLT ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Celgene Corporation (NASDAQ: CELG ) Kodiak Sciences Inc (NASDAQ: KOD ) The Medicines Company (NASDAQ: MDCO ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 17) Aileron Therapeutics Inc (NASDAQ: ALRN ) Alpine Immune Sciences Inc (NASDAQ: ALPN ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Homology Medicines Inc (NASDAQ: FIXX ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM ) Neurometrix Inc (NASDAQ: NURO ) (reacted to its third-quarter results) Puma Biotechnology Inc (NASDAQ: PBYI ) Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) Theratechnologies Inc (NASDAQ: THTX ) Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) Stocks In Focus Intuitive Surgical Q3 Tops Expectations Intuitive Surgical, Inc. (NASDAQ: ISRG ) reported third-quarter earnings per share of $3.43 on revenues of $1.13 billion.
   The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J  2019/09/26 11:54:44 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 25.) Coherus Biosciences Inc (NASDAQ: CHRS ) The Medicines Company (NASDAQ: MDCO ) Down In The Dumps (Biotech stocks that hit 52-week lows Sept. 25.) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Advaxis, Inc. (NASDAQ: ADXS ) AnaptysBio Inc (NASDAQ: ANAB ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) AzurRx BioPharma Inc (NASDAQ: AZRX ) ( announced lackadaisical efficacy data for pancreatic insufficiency drug) BridgeBio Pharma Inc (NASDAQ: BBIO ) Calithera Biosciences Inc (NASDAQ: CALA ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Cellectis SA (NASDAQ: CLLS ) CytomX Therapeutics Inc (NASDAQ: CTMX ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Exagen Inc (NASDAQ: XGN ) (IPOed on Sep. 16) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Gemphire Therapeutics Inc (NASDAQ: GEMP ) Kalvista Pharmaceuticals Inc (NASDAQ: KALV ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Myovant Sciences Ltd (NYSE: MYOV ) Neon Therapeutics Inc (NASDAQ: NTGN ) Novelion Therapeutics Inc (NASDAQ: NVLN ) Nuvectra Corp (NASDAQ: NVTR ) Onconova Therapeutics Inc (NASDAQ: ONTX ) PDS Biotechnology Corp (NASDAQ: PDSB ) Plus Therapeutics Inc (NASDAQ: PSTV ) Sarepta Therapeutics Inc (NASDAQ: SRPT ) Seelos Therapeutics Inc (NASDAQ: SEEL ) Sophiris Bio Inc (NASDAQ: SPHS ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) Stealth BioTherapeutics Corp (NASDAQ: MITO ) Surface Oncology Inc (NASDAQ: SURF ) Tocagen Inc (NASDAQ: TOCA ) Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) Urogen Pharma Ltd (NASDAQ: URGN ) Vaxart Inc (NASDAQ: VXRT ) (announced positive topline results for an early-stage …
   Spring Bank Pharmaceuticals, Inc. (SBPH) Shares March Higher, Can It Continue?  2019/07/22 14:36:00 Zacks Investment Research
As of late, it has definitely been a great time to be an investor in Spring Bank Pharmaceuticals, Inc. (SBPH).
   Spring Bank in clinical collaboration with Roche for SB 11285 in tumors  2020/02/25 13:41:06 Seeking Alpha
Spring Bank Pharmaceuticals (NASDAQ:SBPH) jumps 20% in premarket trading after announcing a clinical collaboration with Roche (OTCQX:RHHBY) (OTCQX:RHHBF) t
   Spring Bank (SBPH) Stops Dosing in HBV Studies, Stock Down  2019/12/27 08:04:00 Zacks Investment Research
Spring Bank (SBPH) declines as it stops dosing and enrolling patients in phase IIb studies on inarigivir.
   The Daily Biotech Pulse: Intuitive Surgical Earnings, Paratek Pulls Out European Application For Antibiotic, Amgen's Evenity In Europe  2019/10/18 11:07:56 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 17) Applied Therapeutics Inc (NASDAQ: APLT ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Celgene Corporation (NASDAQ: CELG ) Kodiak Sciences Inc (NASDAQ: KOD ) The Medicines Company (NASDAQ: MDCO ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 17) Aileron Therapeutics Inc (NASDAQ: ALRN ) Alpine Immune Sciences Inc (NASDAQ: ALPN ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Homology Medicines Inc (NASDAQ: FIXX ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM ) Neurometrix Inc (NASDAQ: NURO ) (reacted to its third-quarter results) Puma Biotechnology Inc (NASDAQ: PBYI ) Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) Theratechnologies Inc (NASDAQ: THTX ) Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) Stocks In Focus Intuitive Surgical Q3 Tops Expectations Intuitive Surgical, Inc. (NASDAQ: ISRG ) reported third-quarter earnings per share of $3.43 on revenues of $1.13 billion.
   The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J  2019/09/26 11:54:44 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 25.) Coherus Biosciences Inc (NASDAQ: CHRS ) The Medicines Company (NASDAQ: MDCO ) Down In The Dumps (Biotech stocks that hit 52-week lows Sept. 25.) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Advaxis, Inc. (NASDAQ: ADXS ) AnaptysBio Inc (NASDAQ: ANAB ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) AzurRx BioPharma Inc (NASDAQ: AZRX ) ( announced lackadaisical efficacy data for pancreatic insufficiency drug) BridgeBio Pharma Inc (NASDAQ: BBIO ) Calithera Biosciences Inc (NASDAQ: CALA ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Cellectis SA (NASDAQ: CLLS ) CytomX Therapeutics Inc (NASDAQ: CTMX ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Exagen Inc (NASDAQ: XGN ) (IPOed on Sep. 16) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Gemphire Therapeutics Inc (NASDAQ: GEMP ) Kalvista Pharmaceuticals Inc (NASDAQ: KALV ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Myovant Sciences Ltd (NYSE: MYOV ) Neon Therapeutics Inc (NASDAQ: NTGN ) Novelion Therapeutics Inc (NASDAQ: NVLN ) Nuvectra Corp (NASDAQ: NVTR ) Onconova Therapeutics Inc (NASDAQ: ONTX ) PDS Biotechnology Corp (NASDAQ: PDSB ) Plus Therapeutics Inc (NASDAQ: PSTV ) Sarepta Therapeutics Inc (NASDAQ: SRPT ) Seelos Therapeutics Inc (NASDAQ: SEEL ) Sophiris Bio Inc (NASDAQ: SPHS ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) Stealth BioTherapeutics Corp (NASDAQ: MITO ) Surface Oncology Inc (NASDAQ: SURF ) Tocagen Inc (NASDAQ: TOCA ) Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) Urogen Pharma Ltd (NASDAQ: URGN ) Vaxart Inc (NASDAQ: VXRT ) (announced positive topline results for an early-stage …
   Spring Bank Pharmaceuticals, Inc. (SBPH) Shares March Higher, Can It Continue?  2019/07/22 14:36:00 Zacks Investment Research
As of late, it has definitely been a great time to be an investor in Spring Bank Pharmaceuticals, Inc. (SBPH).

calendar